Nothing Special   »   [go: up one dir, main page]
Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient

Bone Marrow Transplantation volume 34, pages 183–186 (2004)Cite this article

Access through your institution
Buy or subscribe

Individuals receiving either allogeneic bone marrow transplants,1 or organ transplants,2 are at an increased risk of developing de novo malignancies. Radiation and immunosuppression are both risk factors. As unfortunate as this is, it could allow for detection of tumor cell–hematopoietic cell hybrids in human cancer. In animal models, tumor hybrids were documented through the use of heterologous genetic markers for the tumor and host genotypes, in some cases revealing hybridization with hematopoietic cells.3, 4 In noncancer systems, heterologous markers were used to demonstrate fusion of bone marrow-derived stem cells with tissue cells.5, 6, 7

Tumor cell DNA was amplified using the 176 bp primers, aliquots were subjected to KpnI digestion, and the mixtures were run on agarose gels. Results for tumor samples T2 and T6 are in Figure 2b. Without KpnI (−), a single 176 bp band was seen, whereas with KpnI (+) two bands of 176 and 150 bp were seen, consistent with being A and O allele fragments. Similarly, amplification of tumor samples T5 and T6 with the 193 bp primers and KpnI digestion yielded bands of 193 and 174 bp, as predicted for A and O alleles (Figure 2c). KpnI digestion of tumor sample T19 produced a 193 bp A allele fragment, but no O allele fragment (Figure 2c).

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Ades L, Guardiola P, Socie G . Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems. Blood Rev 2000; 16: 135–146.

    Article  Google Scholar 

  2. Sheil AGR . Cancer in immune-suppressed organ transplant recipients: Aetiology and evolution. Transplant Proc 1998; 30: 2055–2057.

    Article  CAS  Google Scholar 

  3. Pawelek JM . Tumor cell hybridization and metastasis revisited. Melanoma Res 2000; 10: 507–514.

    Article  CAS  Google Scholar 

  4. Chakraborty A, Sodi S, Rachkovsky M et al. A spontaneous murine melanoma lung metastasis comprised of host × tumor hybrids. Cancer Res 2000; 60: 2512–2519.

    CAS  PubMed  Google Scholar 

  5. Vassilopoulos G, Wang P-R, Russell DW . Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422: 901–904.

    Article  CAS  Google Scholar 

  6. Wang X, Willenbring H, Akkari Y et al. Cell fusion is the principle source of bone-marrow-derived hepatocytes. Nature 2003; 422: 897–901.

    Article  CAS  Google Scholar 

  7. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes, and hepatocytes. Nature 2003; 425: 968–973.

    Article  CAS  Google Scholar 

  8. Perkins JL, Neglia JP, Ramsay NKC et al. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up, outcome. Bone Marrow Transplant 2001; 2: 523–526.

    Article  Google Scholar 

  9. Persson H, Bäckvall H, Ponten F et al. Single cell gene mutation analysis using laser-assisted microdissection of tissue sections. Meth Enzymol 2002; 356: 334–343.

    Article  CAS  Google Scholar 

  10. Lee JC-I, Chang J-G . ABO genotyping by polymerase chain reaction. J Forensic Sci 1992; 37: 1269–1275.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Yale Cancer Center, Yale School of Medicine, New Haven, CT, USA

    A Chakraborty, R Lazova & J Pawelek

  2. Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA

    S Davies

  3. Department of Genetics and Pathology, Uppsala University School of Medicine, Uppsala, Sweden

    H Bäckvall & F Ponten

  4. Departments of Therapeutic Radiology and Genetics, Yale School of Medicine, New Haven, CT, USA

    D Brash

Authors
  1. A Chakraborty
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Lazova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Davies
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Bäckvall
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F Ponten
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D Brash
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Pawelek
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chakraborty, A., Lazova, R., Davies, S. et al. Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant 34, 183–186 (2004). https://doi.org/10.1038/sj.bmt.1704547

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704547

This article is cited by

Search

Advanced search

Quick links